Prediction of Response to Neoadjuvant Chemotherapy by Sequential F-18-Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced-Stage Ovarian Cancer
Top Cited Papers
- 20 October 2005
- journal article
- gynecologic cancer
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (30) , 7445-7453
- https://doi.org/10.1200/jco.2005.06.965
Abstract
Purpose The aim of this study was to evaluate sequential F-18-fluorodeoxyglucose positron emission tomography (FDG-PET) to predict patient outcome after the first and third cycle of neoadjuvant che...Keywords
This publication has 42 references indexed in Scilit:
- Cancer of the OvaryNew England Journal of Medicine, 2004
- Neoadjuvant chemotherapy in ovarian cancerExpert Review of Anticancer Therapy, 2004
- Impact of Interval Debulking Surgery on Clinical Outcome in Primary Unresectable FIGO Stage IIIc Ovarian Cancer PatientsOncology, 2003
- Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancerJournal of the American College of Surgeons, 2003
- Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinomaCancer, 2001
- Neoadjuvant Chemotherapy for Advanced Ovarian Cancer: Long-Term SurvivalGynecologic Oncology, 1999
- Neoadjuvant Chemotherapy or Primary Debulking Surgery in Advanced Ovarian Carcinoma: A Retrospective Analysis of 285 PatientsGynecologic Oncology, 1998
- Neoadjuvant Chemotherapy for Advanced Ovarian CancerGynecologic Oncology, 1994
- Surgical staging and cytoreductive surgery of epithelial ovarian cancerCancer, 1993
- Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancerGynecologic Oncology, 1991